tradingkey.logo
tradingkey.logo
Search

Capricor Therapeutics Inc

CAPR
Add to Watchlist
3.850USD
-0.340-8.11%
Close 07-31 16:00ETQuotes delayed by 15 min
222.96MMarket Cap
LossP/E TTM

CAPR Financials

See Capricor Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Capricor Therapeutics Inc Earnings Date

Latest Release
May 12, 2026
EPS / Forecast
-0.59/-0.53
Revenue / Forecast
0.00/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
-100.00%
EPS(YoY)
-2.26
-96.69%
Analyst Rating
HOLD
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-10.57%-0.59
-286.85%-0.62
-41.63%-0.54
-64.09%-0.57
-71.11%-0.53
-543.23%-0.16
-53.30%-0.38
-18.81%-0.35
-1.52%-0.31
91.91%-0.02
---0.25
---0.29
---0.31
---0.31
---0.87
----
----
----
----
----
Revenue
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-7.92%11.13M
-63.44%2.26M
1.38%3.97M
64.29%4.91M
1159.30%12.09M
288.66%6.19M
--3.92M
--2.99M
--959.90K
--1.59M
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
309.28%204.08K
Net Profit
-39.15%-33.94M
-323.95%-30.17M
-95.68%-24.57M
-135.56%-25.91M
-149.04%-24.39M
-833.83%-7.12M
-96.49%-12.56M
-49.32%-11.00M
-26.08%-9.79M
90.13%-762.09K
-0.31%-6.39M
-3.62%-7.37M
0.64%-7.77M
-24.72%-7.72M
-62.04%-6.37M
-49.73%-7.11M
-51.75%-7.82M
-48.17%-6.19M
-0.55%-3.93M
-36.28%-4.75M
Net Margin
----
----
----
----
----
-914.17%-63.94%
-437.41%-555.20%
-47.29%-276.97%
23.26%-199.60%
99.22%-6.30%
---103.31%
---188.04%
---260.10%
---804.34%
---1338.22%
----
----
----
----
----
Gross Margin
----
----
----
----
----
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
-11.51%1.94%
-8.90%1.80%
-26.48%2.67%
-71.34%2.53%
-67.84%2.20%
-65.55%1.98%
-60.03%3.63%
20.20%8.82%
8.94%6.83%
-14.71%5.75%
--9.09%
--7.34%
--6.27%
--6.74%
--6.26%
----
----
----
----
----
Revenue
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-7.92%11.13M
-63.44%2.26M
1.38%3.97M
64.29%4.91M
1159.30%12.09M
288.66%6.19M
--3.92M
--2.99M
--959.90K
--1.59M
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
309.28%204.08K
Operating profit
-47.19%-36.77M
-278.76%-29.16M
-102.03%-26.28M
-139.14%-27.72M
-143.36%-24.98M
-500.79%-7.70M
-89.52%-13.01M
-49.62%-11.59M
-25.43%-10.27M
81.42%-1.28M
-97.39%-6.86M
-33.07%-7.75M
-35.70%-8.18M
-116.87%-6.90M
6.37%-3.48M
-24.31%-5.82M
-35.20%-6.03M
-45.82%-3.18M
-19.28%-3.71M
-46.91%-4.68M
Net Profit
-39.15%-33.94M
-323.95%-30.17M
-95.68%-24.57M
-135.56%-25.91M
-149.04%-24.39M
-833.83%-7.12M
-96.49%-12.56M
-49.32%-11.00M
-26.08%-9.79M
90.13%-762.09K
-0.31%-6.39M
-3.62%-7.37M
0.64%-7.77M
-24.72%-7.72M
-62.04%-6.37M
-49.73%-7.11M
-51.75%-7.82M
-48.17%-6.19M
-0.55%-3.93M
-36.28%-4.75M
Current assets
93.56%283.09M
97.66%322.94M
17.63%100.95M
304.73%124.13M
253.16%146.25M
221.27%163.39M
190.66%85.82M
-21.21%30.67M
-11.12%41.41M
18.58%50.86M
-37.84%29.53M
-26.03%38.92M
-21.87%46.59M
17.71%42.89M
15.03%47.50M
35.87%52.62M
39.93%59.63M
8.20%36.44M
16.36%41.30M
5.96%38.73M
Total current liabilities
50.59%33.64M
70.44%35.84M
37.47%28.15M
27.03%28.40M
-15.34%22.34M
-32.76%21.03M
-37.81%20.48M
-36.41%22.35M
-28.95%26.38M
32.57%31.27M
41.96%32.93M
79.84%35.15M
159.24%37.13M
470.63%23.59M
676.18%23.19M
515.92%19.55M
281.76%14.32M
39.11%4.13M
31.18%2.99M
65.51%3.17M
Total assets
112.19%326.28M
108.79%355.95M
36.03%126.44M
248.95%133.57M
210.99%153.77M
190.26%170.48M
150.19%92.95M
-16.81%38.28M
-8.20%49.44M
17.25%58.73M
-31.11%37.15M
-20.76%46.01M
-17.03%53.86M
21.21%50.09M
25.12%53.93M
45.42%58.07M
49.09%64.92M
19.39%41.33M
19.10%43.10M
7.55%39.93M
Total liabilities
82.16%47.58M
100.48%50.16M
72.45%42.57M
6.79%28.59M
-15.77%26.12M
-30.76%25.02M
-36.60%24.69M
-38.14%26.78M
-34.93%31.01M
-5.68%36.13M
1.14%38.94M
10.02%43.28M
18.32%47.66M
284.54%38.31M
504.94%38.50M
500.57%39.34M
462.28%40.28M
55.20%9.96M
10.13%6.36M
19.70%6.55M
Total equity
118.34%278.70M
110.22%305.79M
22.86%83.87M
812.66%104.98M
592.41%127.65M
543.60%145.46M
3918.69%68.26M
321.15%11.50M
197.04%18.43M
91.76%22.60M
-111.59%-1.79M
-85.42%2.73M
-74.82%6.21M
-62.43%11.79M
-58.01%15.43M
-43.89%18.73M
-32.26%24.64M
11.23%31.37M
20.81%36.74M
5.45%33.38M
Net operating income
-354.73%-29.25M
-59.27%-23.57M
-69.11%-19.69M
-63.75%-20.12M
-407.20%-6.43M
-27.62%-14.80M
-32.38%-11.64M
-30.48%-12.29M
-130.13%-1.27M
-67.98%-11.59M
-54.69%-8.79M
-43.95%-9.42M
-82.49%4.21M
-22.65%-6.90M
-70.33%-5.69M
-44.92%-6.54M
822.26%24.05M
-46.46%-5.63M
-12.10%-3.34M
-123.85%-4.51M
Net investment
-747.29%-154.64M
134.92%43.09M
695.70%15.95M
-0.99%14.55M
351.43%23.89M
-2004.53%-123.38M
-74.04%2.00M
127.43%14.70M
-195.86%-9.50M
-214.01%-5.86M
284.87%7.72M
118.25%6.46M
-413.58%-3.21M
1494.77%5.14M
-791.98%-4.18M
-10882.05%-35.41M
-1594.19%-625.36K
-27.96%-368.67K
-208.01%-468.24K
-200.08%-322.46K
Net financing
2820.64%1.47M
206.85%248.82M
-99.99%6.95K
-99.05%19.58K
-97.80%50.35K
250.01%81.09M
30353.48%67.33M
-5.53%2.07M
58699.59%2.29M
685.45%23.17M
-88.25%221.08K
14481.33%2.19M
-85.82%3.90K
6861.35%2.95M
-71.35%1.88M
-98.55%15.01K
-99.78%27.46K
-97.17%42.37K
201.63%6.57M
-95.88%1.04M

FAQs

What are the current assets of Capricor Therapeutics Inc?

According to Capricor Therapeutics Inc's FY2025 earnings report, its current assets were 322.94M, with a year-on-year change of 97.66.

What are the total assets of Capricor Therapeutics Inc?

According to Capricor Therapeutics Inc's FY2025 earnings report, its total assets of Capricor Therapeutics Inc were 355.95M, with a year-on-year change of 108.79.

What are the total liabilities of Capricor Therapeutics Inc?

According to Capricor Therapeutics Inc's FY2025 earnings report, its total liabilities of Capricor Therapeutics Inc were 50.16M, with a year-on-year change of 100.48.

What is the total equity of Capricor Therapeutics Inc?

According to Capricor Therapeutics Inc's FY2025 earnings report, its total equity of Capricor Therapeutics Inc was 305.79M, with a year-on-year change of 110.22.

What is the net operating income of Capricor Therapeutics Inc?

According to Capricor Therapeutics Inc's FY2025 earnings report, its net operating income of Capricor Therapeutics Inc was -108.14M, with a year-on-year change of -454.13.

What is the net investment of Capricor Therapeutics Inc?

According to Capricor Therapeutics Inc's FY2025 earnings report, its net investment of Capricor Therapeutics Inc was 97.48M, with a year-on-year change of 183.90.

What is the net financing of Capricor Therapeutics Inc?

According to Capricor Therapeutics Inc's FY2025 earnings report, its net financing of Capricor Therapeutics Inc was 248.89M, with a year-on-year change of 62.92.

What is the Earnings Per Share (EPS) of Capricor Therapeutics Inc?

According to Capricor Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.26, with a year-on-year change of -96.69.

What is the net income of Capricor Therapeutics Inc?

According to Capricor Therapeutics Inc's FY2025 earnings report, its net income was -105.04M, with a year-on-year change of -159.58.

What is the debt-to-asset ratio of Capricor Therapeutics Inc?

According to Capricor Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 1.80, with a year-on-year change of -8.90.

What is the Return on Equity (ROE) of Capricor Therapeutics Inc?

According to Capricor Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -46.56, with a year-on-year change of 3.32.

What is the Return on Assets (ROA) of Capricor Therapeutics Inc?

According to Capricor Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -39.91, with a year-on-year change of -13.02.

What is the operating profit of Capricor Therapeutics Inc?

According to Capricor Therapeutics Inc's FY2025 earnings report, its operating profit was -108.14M, with a year-on-year change of -454.13.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.